Accrol Group Holdings plc is a leading independent tissue converter, manufacturing toilet rolls, kitchen rolls, facial tissues and AFH products to supply retailers throughout the UK. Accrol imports parent reels from around the world and converts them into finished goods at the Company’s 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 17 million units per week and supplies some of the UK’s largest retailers.

Accrol Group Holdings plc is listed on AIM, the growth market of the London Stock Exchange.

The Company was incorporated and registered in England and Wales on 30 April 2014 under the Act with registered number 9019496 as a private company limited by shares with the name Aghoco 1220 Limited. The name of the Company was changed to Accrol Group Holdings Limited on 1 August 2014. The Company was re-registered as a public limited company with the name Accrol Group Holdings plc on 1st June 2016. Accrol Group Holdings plc’s main country of operation is the UK.

The Company, and the Group, trade under the name “Accrol Papers”.

Someone clearly buying 18k, 25k and 50k lots. :-))

e-mail to me from the company today regarding the dividend -

So sorry to have taken such long time to respond but we were still sorting out the dates of payment etc.

I now have it confirmed that the shares will become ex dividend on 12 January 2017. The interim dividend will be paid to Members of the Registry at close of business on 13 January 2017.

One again, apologies for the delay.

Thanks
Kathleen

Thank you dreamcatcher it's in the diary, appreciate all your posts very helpful....

I have waited a couple of weeks for the info. Mind you the company always answer. Cheers stevesham.

Notice of interim results date change
RNS
RNS Number : 7679R
Accrol Group Holdings PLC
14 December 2016
 
14 December 2016
 
Accrol Group Holdings plc (the "Company" or "Accrol")
Notice of interim results date change
 
Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce that its interim results will be announced earlier than previously reported, now on Wednesday 4 January 2017.
A presentation to analysts will take place at 9.30am on the 4th January at Camarco's offices at 107 Cheapside, London, EC2V 6DN. Please contact Camarco on the details below for further information

Now there is interesting I wonder why?

Do we think they have some great results they need to get into the market to speed up progress? maybe a move from AIM? maybe record results and can't wait to announce an amazing dividend, whatever it is, my belief is it will be amazing

I hope so. The Interim results are going to be announced on the 4th instead of the 5th, only a day in it, :-))

Reading ST of IC today ,perhaps a bid for Accrol may come one day.


The fact that so many small-cap companies are being taken over is noteworthy, a reflection of the fact that cash-generative and modestly geared businesses with solid balance sheets remain attractive to larger rivals and private equity firms, which are able to readily access cheap credit and gear up the target's balance sheet. I don't expect this activity to end any time soon, a good enough reason to continue to search for companies exhibiting solid finances, and where the differential between earnings yields - the reciprocal of the PE ratio - and the cost of corporate debt is such that there is an incentive for an acquirer to offer a bid premium.
A consequence of the ongoing bid activity in my small-cap space, and the fact that I now have run profit recommendations on literally dozens of my share recommendations, is that I am always on the search for new companies to consider commencing coverage on. Aim listings have proved a fertile hunting ground - tissue maker Accrol (ACRL:128p) and student accommodation construction company Watkin Jones (WJG:118p) are two of the small-cap winners in the new issues market I have managed to screen out from this year's offering. Expect more of the same in the coming year, and one in which I believe the ability of stockpickers to generate above-average returns is likely to come into the fore, a challenge I am relishing already.

Seems to have been a steady sell off over the last couple of months.

On Wednesday, Accrol Group Holdings PLC (ACRL:LSE) closed at 120.00, -14.89% below its 52-week high of 141.00, set on Oct 11, 2016.

Hope for a positive set of results in the morning, due to them being pulled forwards.

Good luck DC £££££'s are coming!

This is what I have been waiting for, hope I am not disappointed as I can only see good news being announced and hopefully get some more good news M&A possibly?

Looking for a nice uplift again tomorrow

Hi stevesham, don't mind the M&A's. I hope we do not get news that someone like Andrex has taken them out. Kimberley-Clarke as you know are an American firm that are huge and they purchased Scott Paper along with the brand Andrex.(A British brand)
A takeover a lot further down the road will be welcomed. This company is an ideal
young company and going to be far cheaper to takeover now then in a few years time.

Interim results

Financial Highlights
·     Revenue increased 8.8% to £63.9m (H1 FY16: £58.7m)
·     Gross Profit increased 5.6% to £18.2m (H1 FY16: £17.2m)
·     Adjusted gross margin improved by 1.1% to 28.4% (H1 FY16: 27.3%) through significant currency hedging pre and post EU referendum and negotiated parent reel pricing
·     Adjusted EBITDA increased 1.5% to £7.1m (H1 FY16: £7.0m)
·     Net debt reduced by £3.2m from £23.1m at flotation to £19.9m at 31 October 2016
·     We have significantly increased our foreign currency facilities and have continued with our existing hedging strategy
·     Maiden interim dividend announced of 2p per ordinary share
Operational Highlights
·     Successful IPO in June 2016 raising £63.5m
·     Our market share of discount sector has increased to circa 50%
·     Significant contract wins previously announced with Booker, Poundstretcher and Lidl
·     Early indications that Lidl contract likely to deliver more than £10m in annual revenue
·     New 168,000 sq. ft. manufacturing facility at Leyland, Lancashire progressing on target with production starting end of January 2017
·     Senior team strengthened in Manufacturing, Supply Chain, HR, Procurement and Engineering. Successful and complete transition of key operations from the Hussain Family to the new Operational Board
·     Operational initiatives underway including; price inflation recovery, manufacturing optimisation and supply chain optimisation

This company will soon be noticed . :-))

Someone looks to have sold 775,415 a director maybe at 15.20 pm.

I saw that. Good write up from Shares today, Might need extra machines in the near future.

The 745,000 sale - no current director holds the level. As the company sounds like it has taken over running the business from the Hussain Family, it may be a member selling up.

Another big 1,275.000 supposed sell gone through , yet it's up . Do i buy .

My main concern is that I hope the Hussain family are blocked legally in writing from setting up 5 miles down the road.

Shareholder Information

Shares In Issue

As at 10th June 2016 the number of shares in issue was 93,012,002
Major Shareholders
As at 10th June 2016, significant shareholdings in the share capital of Accrol Group Holdings plc were:

Majid Hussain*
4,652,590
5.00%

Wajid Hussain*
4,652,590
5.00%
Mozam Hussain*
4,646,621
5.00%

NorthEdge Capital LLP**
13,987,377
15.04%

Miton Asset Management Limited
7,700,000
8.28%

Axa Investment Managers UK
8,400,000
9.03%

Schroder Investment Mgt
7,850,098
8.44%

Majedie Asset Management
5,876,414
6.32%

Ruffer LLP
4,504,200
4.84%

Premier Asset Managers
3,600,000
3.87%

BlackRock Investment Mgt (UK)
2,887,410
3.10%